13F
← All fund report cards

CULLINAN ASSOCIATES INC

13F equity value
$1.2B
Positions
207
Top 10 concentration
41.9%
Quarters / total new picks
32 / 282
13F equity value over time
$0M$982M$2B2017201820192020202120222023202420252026

"13F equity value" = market value of this filer's US-listed long equity positions only. It excludes cash, bonds, non-US and short positions, so it understates a fund's true assets under management — often by a lot.

Not significant Verdict

13F holdings are disclosed ~45 days after quarter-end, and they never reveal when within the quarter a fund actually bought. So any 13F-based summary is structurally late and blurred — this applies to every fund, including this one.

We backtested copying it anyway. Buying this fund's new positions the day each filing went public, over 32 quarters, returned +4.2% per quarter — versus +2.7% per quarter from simply owning every 13F stock. It beat that baseline in only 59.4% of quarters (excess t = 0.37, not statistically significant). Its filings tell you what it bought — not what you should buy.

Avg 2Q excess
+1.2%
t-stat
0.37
Quarterly win rate
59%
Annualized excess
+4.9%
$1 → follow vs universe
$2.96 vs $2.09
Cumulative return: $1 invested in new picks vs universe
1.00 20180331: universe 1.04120180630: universe 0.95920180930: universe 1.00320181231: universe 0.99220190331: universe 0.97520190630: universe 1.04820190930: universe 1.12720191231: universe 0.90920200331: universe 1.09620200630: universe 1.21120200930: universe 1.48520201231: universe 1.55320210331: universe 1.56620210630: universe 1.69220210930: universe 1.51920211231: universe 1.29220220331: universe 1.38720220630: universe 1.28520220930: universe 1.38120221231: universe 1.28220230331: universe 1.35120230630: universe 1.30320230930: universe 1.47920231231: universe 1.54520240331: universe 1.58020240630: universe 1.72320240930: universe 1.70820241231: universe 1.59420250331: universe 1.73820250630: universe 1.79320250930: universe 2.01620251231: universe 2.085 20180331: follow 1.10020180630: follow 1.01220180930: follow 0.94020181231: follow 0.95520190331: follow 1.00820190630: follow 1.06320190930: follow 1.28620191231: follow 1.14420200331: follow 1.20220200630: follow 1.28320200930: follow 1.72720201231: follow 1.72020210331: follow 1.81420210630: follow 2.03420210930: follow 1.66920211231: follow 1.44820220331: follow 1.44620220630: follow 1.21920220930: follow 1.34320221231: follow 1.26920230331: follow 1.38020230630: follow 1.41420230930: follow 1.41620231231: follow 1.49320240331: follow 1.50820240630: follow 2.19620240930: follow 2.20520241231: follow 2.29020250331: follow 2.36120250630: follow 2.58520250930: follow 2.85620251231: follow 2.960 0.84 2.02 3.20 20182019202020212022202320242025 Follow Universe

Quarterly compounding, invested quarters only · entry 47 days after quarter-end (when 13F data becomes public)

Listed as facts. See the verdict above before treating this as signal.

Top 20 holdings of 207 · 2026 Q1

Ticker Value Weight QoQ
AAPL $102M
8.2%
TRIM
KO $100M
8.1%
TRIM
MSFT $58M
4.7%
TRIM
SPGI $52M
4.2%
HOLD
JNJ $45M
3.6%
TRIM
XOM $38M
3.1%
TRIM
SPY $33M
2.7%
TRIM
PG $33M
2.6%
TRIM
GOOGL $30M
2.4%
TRIM
GOOG $28M
2.2%
TRIM
AMZN $25M
2.0%
TRIM
IBM $23M
1.9%
TRIM
VRTX $23M
1.9%
HOLD
JPM $19M
1.5%
TRIM
WMT $18M
1.4%
TRIM
MCD $18M
1.4%
TRIM
AMAT $18M
1.4%
TRIM
CVX $17M
1.4%
TRIM
ABBV $16M
1.3%
TRIM
AFL $15M
1.2%
TRIM

QoQ vs previous quarter's share count · NEW = new position · ADD/TRIM = ±2% shares · HOLD = unchanged.

Listed as facts. See the verdict above before treating this as signal.

New positions in 2026 Q1

Method & Limitations

Method: a "new position" = held this quarter, absent last quarter (options excluded; stocks with <50 prior holders excluded to filter spin-off artifacts). Entry 47 days after quarter-end — the first day the public could act on the filing. Benchmark = equal-weighted universe of all 13F-held stocks. Limitations: quarterly snapshots can't see intra-quarter trades; survivorship bias — funds that shut down are absent, which flatters the sample. Statistics, not advice.